HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.

Precision medicines and personalized treatments are revolutionizing cancer therapy. Small molecules, biological agents, antibody-drug conjugates and cell-based therapies directed against specific ...

通过深度学习技术，研究者对22种高分化胎盘哺乳动物的基因组比对数据进行分析，推断了重组景观的演化历程。他们鉴定出一个占据X染色体30%长度、在演化中高度保守的大型连锁重组基因沙漠。